van der Kamp Hilde Johanna
SEC insider (Form 3/4/5 filer). CIK 0002000565. Director at NewAmsterdam Pharma Co N.V. (NAMS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in NAARDEN, P7.
Companies van der Kamp Hilde Johanna has filed insider reports for
- NewAmsterdam Pharma Co N.V. (NAMS): Director
van der Kamp Hilde Johanna
CIK: 0002000565
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAMS
NewAmsterdam Pharma Co N.V.
Director